Trial
NCT03511105
Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
Biomedical Advanced Research and Development Authority
Condition
Healthy Volunteers
Intervention
GSK2798745
Why stopped
Study terminated due to low probability of achieving a positive outcome on the primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-29